Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

Fig. 3

CEA-expression on colorectal carcinoma cell lines HCT116, WiDr, and LS174T. a Surface CEA-expression levels in colorectal carcinoma cell lines HCT116, WiDr, and LS174T were monitored by flow cytometry. b Determination of CEA protein expression by immunoblotting analysis in colorectal carcinoma cell lines

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us